Page last updated: 2024-11-05

ethyl butyrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl butyrate is a colorless liquid ester with a fruity aroma reminiscent of pineapple and apple. It is commonly used as a flavoring agent in food and beverages. The synthesis of ethyl butyrate involves the esterification reaction of butyric acid with ethanol, often catalyzed by an acid. Ethyl butyrate has been found to exhibit insecticidal activity against certain insect species. It is studied for its potential applications in various fields, including food, pharmaceuticals, and agriculture. Additionally, ethyl butyrate plays a role in the aroma profiles of fruits and fermented products, contributing to their characteristic fragrances.'

ethyl butyrate : A butyrate ester resulting from the formal condensation of the hydroxy group of ethanol with the carboxy group of butyric acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7762
CHEMBL ID44800
CHEBI ID88764
SCHEMBL ID6115
MeSH IDM0132450

Synonyms (63)

Synonym
ccris 6554
brn 0506331
einecs 203-306-4
nsc 8857
butanoic acid ethyl ester
fema number 2427
ethyl butyrate (natural)
un1180
fema no. 2427
ai3-18427
hsdb 406
butyric ether
105-54-4
butyric ester
nsc-8857
ethyl butyrate
ethyl butanoate
wln: 3vo2
nsc8857
ethyl n-butyrate
inchi=1/c6h12o2/c1-3-5-6(7)8-4-2/h3-5h2,1-2h
butanoic acid, ethyl ester
butyric acid, ethyl ester
ethyl butyrate, 99%
ethyl butyrate, >=98%, fcc, fg
ethyl butyrate, natural, >=98%, fcc, fg
B0759
butyric acid ethyl ester
CHEMBL44800
chebi:88764 ,
NCGC00247893-01
dtxsid6040111 ,
NCGC00253968-01
cas-105-54-4
tox21_300065
dtxcid4020111
AKOS008948342
4-02-00-00787 (beilstein handbook reference)
ufd2lz005d ,
unii-ufd2lz005d
ethyl butyrate [un1180] [flammable liquid]
ethyl n-butanoate
un 1180
FT-0623347
ethyl butyrate [fhfi]
ethyl butyrate [mi]
ethyl butyrate [fcc]
ethyl n-butyrate [hsdb]
SCHEMBL6115
n-butyric acid ethyl ester
ethyl ester of butanoic acid
mfcd00009394
J-001444
LMFA07010874
ethyl butyrate, analytical standard
F0001-0107
ethyl 1-butyrate
butyric acid-ethyl ester
fema 2427
Q412270
ethyl butyrate-4,4,4-d3
EN300-54773
?ethyl butyrate

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The toxicity to human bronchial (16-HBE14o-) epithelium cells of nonionic surfactants, polyoxyethylene-10-oleyl ether (C(18:1)E(10)), polyoxyethylene-10-dodecyl ether (C(12)E(10)), and N,N-dimethyl-dodecylamine-N-oxide (C(12)AO) alone or in combination with a range of pharmaceutically acceptable oils (namely, ethyl esters and triglyceride oils), was determined with the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay."( Toxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oil.
Lansley, AB; Lawrence, MJ; Warisnoicharoen, W, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
butyrate esterAny carboxylic ester where the carboxylic acid component is butyric acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency68.58960.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159552; AID1159555
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency61.13060.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (5.88)18.7374
1990's5 (7.35)18.2507
2000's21 (30.88)29.6817
2010's27 (39.71)24.3611
2020's11 (16.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 68.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index68.24 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index113.39 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (68.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.82%)5.53%
Reviews1 (1.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other68 (95.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]